Literature DB >> 19129199

Functional protein delivery into neurons using polymeric nanoparticles.

Linda Hasadsri1, Jörg Kreuter, Hiroaki Hattori, Tadao Iwasaki, Julia M George.   

Abstract

An efficient route for delivering specific proteins and peptides into neurons could greatly accelerate the development of therapies for various diseases, especially those involving intracellular defects such as Parkinson disease. Here we report the novel use of polybutylcyanoacrylate nanoparticles for delivery of intact, functional proteins into neurons and neuronal cell lines. Uptake of these particles is primarily dependent on endocytosis via the low density lipoprotein receptor. The nanoparticles are rapidly turned over and display minimal toxicity to cultured neurons. Delivery of three different functional cargo proteins is demonstrated. When primary neuronal cultures are treated with recombinant Escherichia coli beta-galactosidase as nanoparticle cargo, persistent enzyme activity is measured beyond the period of nanoparticle degradation. Delivery of the small GTPase rhoG induces neurite outgrowth and differentiation in PC12 cells. Finally, a monoclonal antibody directed against synuclein is capable of interacting with endogenous alpha-synuclein in cultured neurons following delivery via nanoparticles. Polybutylcyanoacrylate nanoparticles are thus useful for intracellular protein delivery in vitro and have potential as carriers of therapeutic proteins for treatment of neuronal disorders in vivo.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19129199      PMCID: PMC2652328          DOI: 10.1074/jbc.M805956200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  73 in total

Review 1.  Techniques for gene transfer into neurons.

Authors:  Philip Washbourne; A Kimberley McAllister
Journal:  Curr Opin Neurobiol       Date:  2002-10       Impact factor: 6.627

Review 2.  Solid lipid nanoparticles for targeted brain drug delivery.

Authors:  Paolo Blasi; Stefano Giovagnoli; Aurélie Schoubben; Maurizio Ricci; Carlo Rossi
Journal:  Adv Drug Deliv Rev       Date:  2007-05-22       Impact factor: 15.470

Review 3.  The two faces of protein misfolding: gain- and loss-of-function in neurodegenerative diseases.

Authors:  Konstanze F Winklhofer; Jörg Tatzelt; Christian Haass
Journal:  EMBO J       Date:  2008-01-23       Impact factor: 11.598

4.  Chaperone-mediated autophagy.

Authors:  S Kaushik; A M Cuervo
Journal:  Methods Mol Biol       Date:  2008

5.  Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells.

Authors:  Tereza Vogiatzi; Maria Xilouri; Kostas Vekrellis; Leonidas Stefanis
Journal:  J Biol Chem       Date:  2008-06-19       Impact factor: 5.157

6.  Tat-Hsp70 protects dopaminergic neurons in midbrain cultures and in the substantia nigra in models of Parkinson's disease.

Authors:  Florian Nagel; Björn H Falkenburger; Lars Tönges; Sebastian Kowsky; Charlotte Pöppelmeyer; Jörg B Schulz; Mathias Bähr; Gunnar P H Dietz
Journal:  J Neurochem       Date:  2007-12-24       Impact factor: 5.372

Review 7.  The role of alpha-synuclein in neurodegenerative diseases: a potential target for new treatment strategies?

Authors:  M Windisch; H Wolf; B Hutter-Paier; R Wronski
Journal:  Neurodegener Dis       Date:  2008-03-06       Impact factor: 2.977

Review 8.  Protein misfolding and neurodegeneration.

Authors:  Claudio Soto; Lisbell D Estrada
Journal:  Arch Neurol       Date:  2008-02

9.  Specific AAV serotypes stably transduce primary hippocampal and cortical cultures with high efficiency and low toxicity.

Authors:  Nicolas C Royo; Luk H Vandenberghe; Jing-Yuan Ma; Alisse Hauspurg; Liya Yu; Margaret Maronski; Julie Johnston; Marc A Dichter; James M Wilson; Deborah J Watson
Journal:  Brain Res       Date:  2007-11-17       Impact factor: 3.252

Review 10.  Nonviral approaches for neuronal delivery of nucleic acids.

Authors:  Jamie M Bergen; In-Kyu Park; Philip J Horner; Suzie H Pun
Journal:  Pharm Res       Date:  2007-10-12       Impact factor: 4.200

View more
  33 in total

Review 1.  Nanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases.

Authors:  Howard E Gendelman; Vellareddy Anantharam; Tatiana Bronich; Shivani Ghaisas; Huajun Jin; Anumantha G Kanthasamy; Xinming Liu; JoEllyn McMillan; R Lee Mosley; Balaji Narasimhan; Surya K Mallapragada
Journal:  Nanomedicine       Date:  2015-01-31       Impact factor: 5.307

2.  Computational design and experimental characterization of peptides intended for pH-dependent membrane insertion and pore formation.

Authors:  Yao Zhang; René Bartz; Gevorg Grigoryan; Michael Bryant; Jeff Aaronson; Stephen Beck; Nathalie Innocent; Lee Klein; William Procopio; Tom Tucker; Vasant Jadhav; David M Tellers; William F DeGrado
Journal:  ACS Chem Biol       Date:  2015-01-28       Impact factor: 5.100

Review 3.  Nanomedicine to Overcome Current Parkinson's Treatment Liabilities: A Systematic Review.

Authors:  Gabriel Henrique Hawthorne; Marcelo Picinin Bernuci; Mariza Bortolanza; Vitor Tumas; Ana Carolina Issy; Elaine Del-Bel
Journal:  Neurotox Res       Date:  2016-08-31       Impact factor: 3.911

4.  Efficacy of Cisplatin-loaded polybutyl cyanoacrylate nanoparticles on the glioblastoma.

Authors:  Hasan Ebrahimi Shahmabadi; Fatemeh Movahedi; Maedeh Koohi Moftakhari Esfahani; Seyed Ebrahim Alavi; Ali Eslamifar; Gholamreza Mohammadi Anaraki; Azim Akbarzadeh
Journal:  Tumour Biol       Date:  2014-01-19

Review 5.  Synthetic biology in mammalian cells: next generation research tools and therapeutics.

Authors:  Florian Lienert; Jason J Lohmueller; Abhishek Garg; Pamela A Silver
Journal:  Nat Rev Mol Cell Biol       Date:  2014-01-17       Impact factor: 94.444

6.  New applications of nanotechnology for neuroimaging.

Authors:  G Suffredini; J E East; L M Levy
Journal:  AJNR Am J Neuroradiol       Date:  2013-03-28       Impact factor: 3.825

7.  Alternating Magnetic Field Controlled, Multifunctional Nano-Reservoirs: Intracellular Uptake and Improved Biocompatibility.

Authors:  Santaneel Ghosh; Somesree Ghoshmitra; Tong Cai; David R Diercks; Nathaniel C Mills; Dianna L Hynds
Journal:  Nanoscale Res Lett       Date:  2009-10-25       Impact factor: 4.703

8.  Peptides that mimic the amino-terminal end of the rabies virus phosphoprotein have antiviral activity.

Authors:  Guillaume Castel; Mohamed Chtéoui; Grégory Caignard; Christophe Préhaud; Stéphanie Méhouas; Eléonore Réal; Corinne Jallet; Yves Jacob; Rob W H Ruigrok; Noël Tordo
Journal:  J Virol       Date:  2009-08-12       Impact factor: 5.103

Review 9.  Neurodegenerative disorders and nanoformulated drug development.

Authors:  Ari Nowacek; Lisa M Kosloski; Howard E Gendelman
Journal:  Nanomedicine (Lond)       Date:  2009-07       Impact factor: 5.307

Review 10.  Nanotechnology for protein delivery: Overview and perspectives.

Authors:  Mikyung Yu; Jun Wu; Jinjun Shi; Omid C Farokhzad
Journal:  J Control Release       Date:  2015-10-13       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.